Tsubasa Kameoka, MD

Miyoshi central hospital

Miyoshi, Hiroshima

Disclosures:

Employment: none
Compensation: none
Ownership: none
Leadership: none

Presentations

Sep 28

2396 - The Effect of Adding Consolidation Durvalumab to Hypofractionated Involved-Field Radiotherapy with Concurrent Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer: Does Durvalumab Consolidation Therapy Bring Survival Benefits?

Hall F

04:45pm - 06:00pm PT